Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Loren David Walensky, M.D.,Ph.D.

Co-Author

This page shows the publications co-authored by Loren Walensky and Kimberly Stegmaier.
Connection Strength

0.438
  1. Precision Targeting of BFL-1/A1 and an ATM Co-dependency in Human Cancer. Cell Rep. 2018 09 25; 24(13):3393-3403.e5.
    View in: PubMed
    Score: 0.195
  2. Genome-scale CRISPR-Cas9 screen identifies druggable dependencies in TP53 wild-type Ewing sarcoma. J Exp Med. 2018 08 06; 215(8):2137-2155.
    View in: PubMed
    Score: 0.193
  3. MDM2 and MDM4 Are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors. Cancer Res. 2019 05 01; 79(9):2404-2414.
    View in: PubMed
    Score: 0.050
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.